Working capital / assets moved 2611 bp higher
Working capital / assets changed +2611 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets changed +2611 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed -32.9% from the comparable as-filed period.
Current liabilities changed -37.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -967 basis points from the comparable as-filed period.
Gross margin changed +690 basis points from the comparable as-filed period.
Inventory / revenue changed +2735 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +36.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Cost of revenue changed -40.1% from the comparable as-filed period.
Working capital changed +63.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +104.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current assets changed +27.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
SBC / revenue changed +486 basis points from the comparable as-filed period.
Current ratio changed +103.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Capital expenditure changed -77.8% from the comparable as-filed period.
Operating income changed -246.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Receivables / revenue changed +3716 basis points from the comparable as-filed period.
Cash & equivalents changed -13.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed -23.4% from the comparable as-filed period.
Gross profit changed -19.9% from the comparable as-filed period.
Capex / revenue changed -105 basis points from the comparable as-filed period.
Inventory changed -10.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Total assets changed +10.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Trade receivables changed +6.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Shares outstanding changed +2.1% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
R&D / revenue changed +110 basis points from the comparable as-filed period.
Current liabilities changed +74.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed +67.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +41.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed -320.6% from the comparable as-filed period.
Revenue changed -33.7% from the comparable as-filed period.
Gross margin changed +778 basis points from the comparable as-filed period.
Operating margin changed -6914 basis points from the comparable as-filed period.
Cash & equivalents changed +104.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory / revenue changed +4482 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed +64.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +67.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Research & development changed -44.1% from the comparable as-filed period.
SBC / revenue changed +556 basis points from the comparable as-filed period.
Receivables / revenue changed +3883 basis points from the comparable as-filed period.
Working capital / assets changed +935 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Shares outstanding changed +13.8% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Capital expenditure changed -31.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
R&D / revenue changed -168 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Trade receivables changed +17.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed -17.3% from the comparable as-filed period.
Capex / revenue changed +4 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory changed -5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +2.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed -4.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.